RE: 21 trading days left in July2 Jul 2020 11:02
Totally agree. The science speaks for itself. A key thing for me is the trial expansion, if it wasn't for that, I feel this would have been a complete gamble. You simply never increase a trials recruitment criteria, especially to less sick patients if firstly, the drug isnt safe and secondly if efficacy signals are being shown (from a financial and more importantly, ethical point of view). On top of that, they even expanded recruitment for the "less sick" cohort of patients who are receiving treatment at home. This was the game changer for me hence why I expect positive results for the primary endpoints. With a positive RNS, I don't expect this to rocket to 1 pound like some here think it will, but to the 60-70p mark. Following a positive trial, I expect speedy marketing authorisation and a potential big pharma company stepping in to help produce and distribute.